Biomx Inc logo

PHGE - Biomx Inc News Story

$6.38 0.0  0.3%

Last Trade - 3:34pm

Sector
Healthcare
Size
Small Cap
Market Cap £256.2m
Enterprise Value £215.5m
Revenue £n/a
Position in Universe 3937th / 6850

BRIEF-Biomx Inc Says Results From Phase 2 Cosmetic Clinical Study Of BX001 Expected In Q2 Of 2021

Thu 14th May, 2020 11:50am
May 14 (Reuters) - Biomx Inc  PHGE.A :
    * BIOMX REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND
PROVIDES
BUSINESS UPDATE
    * BIOMX INC - CASH AND EQUIVALENTS OF $75.3 MILLION EXPECTED
TO
FUND CURRENT OPERATING PLAN FOR AT LEAST 24 MONTHS
    * BIOMX INC - RESULTS FROM PHASE 2 COSMETIC CLINICAL STUDY
OF
BX001 EXPECTED IN Q2 OF 2021
    * BIOMX INC - BIOMX'S GUIDANCE ON TIMING OF CERTAIN CLINICAL
MILESTONES HAS EVOLVED
    * BIOMX INC - CASH BALANCE AND SHORT-TERM DEPOSITS AS OF
MARCH 31,
2020, WERE $75.3 MILLION, COMPARED TO $82.3 MILLION AS OF
DECEMBER 31, 2019

Source text for Eikon:  ID:nBw81bvVma 
Further company coverage:  PHGE.A 

 (Reuters.Briefs@thomsonreuters.com)
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.